ICU Medical (ICUI) director sells 1,285 shares; now holds 3,995

ICU Medical (ICUI) Form 4: Director Elisha W. Finney exercised 1,285 non-qualified stock options at $103.76 and, on the same day (11/11/2025), sold 1,285 shares at $140.42.

Rhea-AI Filing Summary

ICU Medical (ICUI) Form 4: Director Elisha W. Finney exercised 1,285 non-qualified stock options at $103.76 and, on the same day (11/11/2025), sold 1,285 shares at $140.42. Following these transactions, she directly owns 3,995 shares.

The option carried a $103.76 exercise price, became exercisable on 06/15/2016, and expires on 01/08/2026; derivative securities beneficially owned after the transactions were 0.

Insider Trade Summary

Exercise and Sale: 1,285 shares ($47K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider FINNEY ELISHA W

Role Director

Sold 1,285 shs ($180K)

Approx. gross sale proceeds $180K

Approx. exercise cost $133K

Approx. pre-tax spread $47K

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy)	1,285	$0.00	$0.00
Exercise	Common Stock	1,285	$103.76	$133K
Sale	Common Stock	1,285	$140.42	$180K

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 3,995 shares (Direct)

Footnotes (1)

1. F1. All shares sold were sold at the exact price disclosed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction was reported for ICUI?

Director Elisha W. Finney exercised 1,285 options at $103.76 and sold 1,285 shares at $140.42 on 11/11/2025.

How many ICUI shares does the reporting person hold after the transaction?

Directly owned shares after the transactions total 3,995.

What type of derivative was involved and at what price?

A non-qualified stock option with an exercise price of $103.76.

When do the option rights expire?

The option expires on 01/08/2026.

How many derivative securities remain after the reported transactions?

Derivative securities beneficially owned after the transactions were 0.

What was the sale price for the ICUI shares?

Shares were sold at $140.42 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 10:59 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FINNEY ELISHA W

(Last) (First) (Middle)

951 CALLE AMANECER

(Street)

SAN CLEMENTE CA 92673

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/11/2025		M		1,285	A	$103.76	5,280	D
Common Stock	11/11/2025		S		1,285	D	$140.42(1)	3,995	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$103.76	11/11/2025		M			1,285	06/15/2016	01/08/2026	Common Stock	1,285	$0.0	0	D

Explanation of Responses:

1. All shares sold were sold at the exact price disclosed.

	By: Paula Darbyshire, Attorney-in-Fact For: Elisha W Finney	11/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.